VDO-52

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVDO-52
Drug Alias NamePPAR gamma agonists (Vita-Invest)Type II diabetes therapeutics (Vita-Invest)thiazolidinediones (Vita-Invest)VDO-52
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVita-Invest SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVita-Invest SA
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A